|
Volumn 111, Issue 23, 2005, Pages 3167-3184
|
Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association - Executive summary
|
Author keywords
AHA scientific statements; Drugs; Echocardiography; Endocardium; Infection
|
Indexed keywords
AMPICILLIN;
ANTIINFECTIVE AGENT;
CEFAZOLIN;
CEFEPIME;
CEFTRIAXONE;
CILASTATIN PLUS IMIPENEM;
CIPROFLOXACIN;
DALFOPRISTIN PLUS QUINUPRISTIN;
DOXYCYCLINE;
GENTAMICIN;
LINEZOLID;
NAFCILLIN;
OXACILLIN;
PENICILLIN G SODIUM;
RIFAMPICIN;
STREPTOMYCIN SULFATE;
SULTAMICILLIN;
VANCOMYCIN;
ACTINOBACILLUS;
ALPHA HEMOLYTIC STREPTOCOCCUS;
ANTIMICROBIAL THERAPY;
ARTICLE;
BACTERIAL ENDOCARDITIS;
BARTONELLA;
CARDIOBACTERIUM;
CONGESTIVE HEART FAILURE;
ECHOCARDIOGRAPHY;
EIKENELLA;
EMBOLISM;
ENTEROBACTERIACEAE;
ENTEROCOCCUS;
HAEMOPHILUS;
HEALTH CARE PERSONNEL;
KINGELLA;
LONG TERM CARE;
MEDICAL EXPERT;
MEDICAL PRACTICE;
MEDICAL SOCIETY;
MYCOTIC ANEURYSM;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PSEUDOMONAS;
SALMONELLA;
SCORING SYSTEM;
SHORT COURSE THERAPY;
STAPHYLOCOCCUS;
STREPTOCOCCUS BOVIS;
|
EID: 20744431788
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/CIRCULATIONAHA.105.165563 Document Type: Article |
Times cited : (173)
|
References (0)
|